Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
: Significant numbers of variants detected in cancer patients are often left labeled only as variants of unknown significance (VUS). In order to expand precision medicine to a wider population, we need to extend our knowledge of pathogenicity and drug response in the context of VUS’s. | Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients